德诺苏马布
医学
中止
骨矿物
背景(考古学)
加药
股骨颈
骨质疏松症
置信区间
内科学
泌尿科
古生物学
生物
作者
Houchen Lyu,Sizheng Steven Zhao,Kazuki Yoshida,Sara K. Tedeschi,Chang Xu,Sagar U. Nigwekar,Benjamin Z. Leder,Daniel H. Solomon
标识
DOI:10.1210/clinem/dgz321
摘要
A longer interval between denosumab injections is associated with suboptimal BMD response at both spine and total hip. Strategies to improve the timely administration of denosumab in real-world settings are needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI